Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Jul;74(1):173–184. doi: 10.1172/JCI111399

Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.

G F Barnard, S K Erickson, A D Cooper
PMCID: PMC425198  PMID: 6330173

Abstract

In contrast to normal liver, it is known that in vivo hepatomas fail to decrease their rate of cholesterol biosynthesis in response to increased dietary cholesterol. From a consideration of the available data it has been hypothesized that the defect might lie in the delivery of cholesterol to the hepatoma cell. To study this further, lipoprotein interactions with rat hepatoma cells in tissue culture (HTC 7288C) and with the same cell line in vivo were investigated. HTC cells grown in a medium containing 10% calf serum exhibited saturable, specific, calcium-dependent binding of rat 125I-chylomicron remnants at 4 degrees C with half maximal saturation at 4.8 micrograms protein/ml and maximum binding of 96 ng protein/10(6) cells. At 4 degrees C, HTC cells also bound human 125I-low density lipoprotein (LDL) specifically, but bound it with a much lower affinity. These cells also exhibited specific binding for rat LDL and rat hypercholesterolemic very low density lipoprotein (VLDL). All these lipoproteins were degraded by HTC cells. Thus, it was concluded that hepatoma cells possess lipoprotein receptors that recognize and process LDL, VLDL, and chylomicron remnants. Overnight incubation of HTC cells in lipid-depleted medium containing 0.5 microM compactin increased binding of rat chylomicron remnants and of hypercholesterolemic VLDL approximately 1.7-fold without a significant change in binding affinity. LDL binding also increased, by approximately 3.5-fold. These changes were also observed when binding and internalization were measured at 37 degrees C. After HTC cells were incubated in lipid-depleted medium, the rate at which [14C]acetate was incorporated into [14C]cholesterol increased 2.5-fold. Inclusion of rat chylomicron remnants at 5-10 micrograms protein/ml prevented this increase in acetate incorporation or, if added after culture in lipid-depleted medium, reduced the increased levels back to control values. However, the rate of acetate incorporation into cholesterol by cells grown in complete medium was not decreased to levels below base line by rat chylomicron remnants. Inclusion of human LDL only partially prevented the rise or only partially reduced the increased levels back to control and did not reduce control levels below base line. Hypercholesterolemic VLDL, which contain more cholesterol per particle than chylomicron remnants, did reduce [14C]acetate incorporation to below control levels. Therefore, the intracellular mechanism for down regulation of cholesterol synthesis by lipoproteins is intact in these cells. Based on these results we hypothesized that a relative lack of lipoprotein receptors expressed by hepatomas in vivo in comparison with those expressed by normal liver would explain the apparent absence of feedback inhibition of cholesterol synthesis. Consistent with this hypothesis, the binding of chylomicron remnants to liver cell membranes was 3-5 times greater than to membranes from tumors grown in vivo subcutaneously or intramuscularly. Membranes from tumor cells grown in vitro bound remnants least well. It is proposed that the relative lack of receptors places the hepatoma at a disadvantage in competing with the liver for lipoproteins of dietary origin and may account for the lack of feedback regulation of cholesterol synthesis in hepatomas.

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basu S. K., Goldstein J. L., Brown M. S. Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts. J Biol Chem. 1978 Jun 10;253(11):3852–3856. [PubMed] [Google Scholar]
  2. Beirne O. R., Watson J. A. Comparison of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in hepatoma cells grown in vivo and in vitro. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2735–2739. doi: 10.1073/pnas.73.8.2735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell J. J., Sargeant T. E., Watson J. A. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in hepatoma tissue culture cells by pure cholesterol and several cholesterol derivatives. Evidence supporting two distinct mechanisms.20l. J Biol Chem. 1976 Mar 25;251(6):1745–1758. [PubMed] [Google Scholar]
  4. Brown M. S., Dana S. E., Siperstein M. D. Properties of 3-hydroxy-3-methylglutaryl coenzyme A reductase solubilized from rat liver and hepatoma. J Biol Chem. 1974 Oct 25;249(20):6585–6589. [PubMed] [Google Scholar]
  5. Brown M. S., Faust J. R., Goldstein J. L., Kaneko I., Endo A. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem. 1978 Feb 25;253(4):1121–1128. [PubMed] [Google Scholar]
  6. Chisolm G. M., 3rd, Sila C. A., Hmiel S. P. Measurements of the degradation products of radioiodinated proteins. Anal Biochem. 1981 Mar 1;111(2):212–219. doi: 10.1016/0003-2697(81)90556-x. [DOI] [PubMed] [Google Scholar]
  7. Cooper A. D., Erickson S. K., Nutik R., Shrewsbury M. A. Characterization of chylomicron remnant binding to rat liver membranes. J Lipid Res. 1982 Jan;23(1):42–52. [PubMed] [Google Scholar]
  8. Cooper A. D., Ockner R. K. Studies of hepatic cholesterol synthesis in experimental acute biliary obstruction. Gastroenterology. 1974 Apr;66(4):586–595. [PubMed] [Google Scholar]
  9. Cooper A. D. The metabolism of chylomicron remnants by isolated perfused rat liver. Biochim Biophys Acta. 1977 Sep 28;488(3):464–474. doi: 10.1016/0005-2760(77)90204-1. [DOI] [PubMed] [Google Scholar]
  10. Cooper A. D., Yu P. Y. Rates of removal and degradation of chylomicron remnants by isolated perfused rat liver. J Lipid Res. 1978 Jul;19(5):635–643. [PubMed] [Google Scholar]
  11. Dietschy J. M., Wilson J. D. Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control. J Clin Invest. 1968 Jan;47(1):166–174. doi: 10.1172/JCI105706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Drevon C. A., Attie A. D., Pangburn S. H., Steinberg D. Metabolism of homologous and heterologous lipoproteins by cultured rat and human skin fibroblasts. J Lipid Res. 1981 Jan;22(1):37–46. [PubMed] [Google Scholar]
  13. Florén C. H., Albers J. J., Kudchodkar B. J., Bierman E. L. Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts. J Biol Chem. 1981 Jan 10;256(1):425–433. [PubMed] [Google Scholar]
  14. Florén C. H., Nordgren H., Nilsson A. Effects of chloroquine and colchicine on the degradation of chyle cholesteryl ester and phospholipids in vivo. Eur J Biochem. 1977 Nov 1;80(2):331–340. doi: 10.1111/j.1432-1033.1977.tb11887.x. [DOI] [PubMed] [Google Scholar]
  15. GOULD R. G. Lipid metabolism and atherosclerosis. Am J Med. 1951 Aug;11(2):209–227. doi: 10.1016/0002-9343(51)90107-6. [DOI] [PubMed] [Google Scholar]
  16. George R., Goldfarb S. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in Morris hepatoma 7800 after intravenous injection of mevalonic acid. Cancer Res. 1980 Dec;40(12):4717–4721. [PubMed] [Google Scholar]
  17. Goldstein J. L., Brown M. S. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2804–2808. doi: 10.1073/pnas.70.10.2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  19. Gregg R. G., Sabine J. R., Wilce P. A. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in rat liver and Morris hepatomas 5123C, 9618A and 5123t.c. Biochem J. 1982 May 15;204(2):457–462. doi: 10.1042/bj2040457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harry D. S., Morris H. P., McIntyre N. Cholesterol biosynthesis in transplantable hepatomas: evidence for impairment of uptake and storage of dietary cholesterol. J Lipid Res. 1971 May;12(3):313–317. [PubMed] [Google Scholar]
  21. Horton B. J., Mott G. E., Pitot H. C., Goldarb S. Rapid uptake of dietary cholesterol by hyperplastic liver nodules and primary hepatomas. Cancer Res. 1973 Mar;33(3):460–464. [PubMed] [Google Scholar]
  22. Hui D. Y., Innerarity T. L., Mahley R. W. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. J Biol Chem. 1981 Jun 10;256(11):5646–5655. [PubMed] [Google Scholar]
  23. Innerarity T. L., Pitas R. E., Mahley R. W. Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells. Requirements for homology for receptor binding activity. J Biol Chem. 1980 Dec 10;255(23):11163–11172. [PubMed] [Google Scholar]
  24. Ishikawa T. T., MacGee J., Morrison J. A., Glueck C. J. Quantitative analysis of cholesterol in 5 to 20 microliter of plasma. J Lipid Res. 1974 May;15(3):286–291. [PubMed] [Google Scholar]
  25. Kovanen P. T., Basu S. K., Goldstein J. L., Brown M. S. Low density lipoprotein receptors in bovine adrenal cortex. II. Low density lipoprotein binding to membranes prepared from fresh tissue. Endocrinology. 1979 Mar;104(3):610–616. doi: 10.1210/endo-104-3-610. [DOI] [PubMed] [Google Scholar]
  26. Kris-Etherton P. M., Cooper A. D. Studies on the etiology of the hyperlipemia in rats fed an atherogenic diet. J Lipid Res. 1980 May;21(4):435–442. [PubMed] [Google Scholar]
  27. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  28. Mitchell A. D., Pugh T. D., Goldfarb S. Partial "feedback control" of beta-hydroxy-beta-methylglutaryl coenzyme A reductase activity in primary hepatocellular carcinomas. Cancer Res. 1978 Dec;38(12):4474–4477. [PubMed] [Google Scholar]
  29. Pattnaik N. M., Zilversmit D. B. Effect of size and competition by lipoproteins and apolipoproteins on the uptake of chylomicrons and chylomicron remnants by hepatoma cells in culture. Biochim Biophys Acta. 1980 Feb 22;617(2):335–346. doi: 10.1016/0005-2760(80)90175-7. [DOI] [PubMed] [Google Scholar]
  30. Redgrave T. G. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest. 1970 Mar;49(3):465–471. doi: 10.1172/JCI106255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Redgrave T. G., Snibson D. A. Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid rats. Metabolism. 1977 May;26(5):493–503. doi: 10.1016/0026-0495(77)90093-2. [DOI] [PubMed] [Google Scholar]
  32. Ross A. C., Zilversmit D. B. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits. J Lipid Res. 1977 Mar;18(2):169–181. [PubMed] [Google Scholar]
  33. SIPERSTEIN M. D., FAGAN V. M. DELETION OF THE CHOLESTEROL-NEGATIVE FEEDBACK SYSTEM IN LIVER TUMORS. Cancer Res. 1964 Aug;24:1108–1115. [PubMed] [Google Scholar]
  34. Schneider W. J., Beisiegel U., Goldstein J. L., Brown M. S. Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem. 1982 Mar 10;257(5):2664–2673. [PubMed] [Google Scholar]
  35. Shelburne F., Hanks J., Meyers W., Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J Clin Invest. 1980 Mar;65(3):652–658. doi: 10.1172/JCI109710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sherrill B. C., Dietschy J. M. Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver. J Biol Chem. 1978 Mar 25;253(6):1859–1867. [PubMed] [Google Scholar]
  37. Sherrill B. C., Innerarity T. L., Mahley R. W. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem. 1980 Mar 10;255(5):1804–1807. [PubMed] [Google Scholar]
  38. Sigurdsson G., Noel S. P., Havel R. J. Catabolism of the apoprotein of low density lipoproteins by the isolated perfused rat liver. J Lipid Res. 1978 Jul;19(5):628–634. [PubMed] [Google Scholar]
  39. Siperstein M. D., Fagan V. M. Feedback control of mevalonate synthesis by dietary cholesterol. J Biol Chem. 1966 Feb 10;241(3):602–609. [PubMed] [Google Scholar]
  40. Van Zuiden P. E., Erickson S. K., Cooper A. D. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion. J Lipid Res. 1983 Apr;24(4):418–428. [PubMed] [Google Scholar]
  41. Windler E., Chao Y., Havel R. J. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J Biol Chem. 1980 Jun 10;255(11):5475–5480. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES